← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Endoprotech, Inc.
Louisville, KY
$4,489,258
Total funding
6
Grants
Funding over time
peak $974.5K · FY2005–19$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$4,489,258 · 6
By mechanism
R44$2,900,095 · 2
R42$963,666 · 1
R43$502,519 · 2
R41$122,978 · 1
Investigators at Endoprotech, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Novel Drug Carrier System for the Treatment of Alcoholic Liver Disease$749,725
R44 · FY2016 · AA
A Novel Lipotherapy to Reduce Infarct Size Following Myocardial Infarction$749,712
R44 · FY2018 · HL
A Novel Lipotherapy to Reduce Infarct Size Following Myocardial Infarction$736,042
R44 · FY2019 · HL
Novel Drug Carrier System for the Treatment of Alcoholic Liver Disease$664,616
R44 · FY2015 · AA
New anti-complement therapy to reduce reperfusion injury: Phase II$498,890
R42 · FY2008 · HL
New anti-complement therapy to reduce reperfusion injury: Phase II$464,776
R42 · FY2009 · HL
Device for Delivery of Rolipram to Liver for Treatment of Alcoholic Liver Disease$277,707
R43 · FY2012 · AA
A Novel Lipotherapy to Reduce Infarct Size Following Myocardial Infarction$224,812
R43 · FY2016 · HL
New anti-complement therapy to reduce reperfusion injury$122,978
R41 · FY2005 · HL